CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 500 enrolled
Drug / intervention
iFR pullbackother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03084367
NCT03084367N/ACompleted

DEFINE PCI: Physiologic Assessment of Coronary Stenosis Following PCI

Volcano Corporation·observational·Posted Mar 20, 2017·Updated May 10, 2022

In Brief

An observational study evaluating iFR pullback for Coronary Artery Disease and 3 related conditions. Completed, enrolled 500 participants across 28 sites in 3 countries.

Detailed Summary

This is a pilot study designed to assess the relationship between iFR (instantaneous wave-free ratio) pullback and the distribution of coronary atheroma/stenoses as assessed by Quantitative Coronary Angiography (QCA) post angiographically successful PCI (Percutaneous Coronary Intervention).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands, United Kingdom, United States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 20, 2017
Enrollment StartJun 20, 2017
Primary CompletionJan 18, 2019
Study CompletionFeb 18, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 9.3 years ago

Interventions

iFR pullbackother

iFR pullback assessment post angiographically successful PCI